Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Innovations From 'Down-Under': A Focus on Prescription to Non-Prescription Medicine Reclassification in New Zealand and Australia

    Access Status
    Fulltext not available
    Authors
    Gauld, N.
    Kelly, F.
    Emmerton, Lynne
    Bryant, L.
    Buetows, S.
    Date
    2012
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Gauld, Natalie and Kelly, Fiona and Emmerton, Lynne and Bryant, Linda and Buetows, Stephen. 2012. Innovations from 'Down-Under': A Focus on Prescription to Non-Prescription Medicine Reclassification in New Zealand and Australia. Self Care. 3 (5): pp. 88-107.
    Source Title
    Self Care
    Additional URLs
    http://www.selfcarejournal.com/view.abstract.php?id=10083
    ISSN
    2042-7018
    URI
    http://hdl.handle.net/20.500.11937/42213
    Collection
    • Curtin Research Publications
    Abstract

    Background: Australia and New Zealand (NZ) contribute to the international trend of medicines reclassification from prescription to non-prescription availability (switch). Both countries have been acknowledged as being as advanced or even more so than the United Kingdom (UK) in availability of medicines without prescription, despite not making some of the recent innovative UK switches. Objective: To derive a measure of progressiveness in switch; to compare the progressiveness of switch between NZ and Australia; and to compare NZ and Australia switch activity with the UK. Methods: Records of medicines classification meetings in Australia and NZ from 2000 to 2011 were analysed with respect to all switch considerations (whether approved or not approved). Switches in Australia and NZ were compared with those in the UK. A new measure, ‘innovative switches’, was developed to provide a useful measure of switch progress. Results: Australia demonstrated ‘switch innovation’ in the early 2000s, including the ‘first-in-world’ switch of orlistat, but has slowed down since. Recently NZ has become more innovative than Australia with first-in-world switches of oseltamivir, famciclovir and calcipotriol. Switches driven by sponsors, and also non-sponsors, and exemption to prescription supply have facilitated consumer access to medicines in NZ. However, medicines that were switched in the UK but not Australasia indicate locality-specific barriers. Conclusions: Australia and NZ have both been progressive with medicines reclassification in the past 12 years, albeit with fewer innovative switches in Australia recently. NZ has become more innovative since 2004 and is now one of the more progressive countries in this trend. Our ‘innovative switch’ framework demonstrates potential for ongoing monitoring of international developments.

    Related items

    Showing items related by title, author, creator and subject.

    • Widening Consumer Access to Medicines through Switching Medicines to Non-Prescription: A Six Country Comparison
      Gauld, N.; Kelly, F.; Kurosawa, N.; Bryant, L.; Emmerton, Lynne; Buetow, S. (2014)
      Background: Switching or reclassifying medicines with established safety profiles from prescription to non-prescription aims to increase timely consumer access to medicines, reduce under-treatment and enhance self-management. ...
    • Widening consumer access to medicines: A comparison of prescription to non-prescription medicine switch in Australia and New Zealand
      Gauld, N.; Kelly, F.; Emmerton, Lynne; Buetow, S. (2015)
      Background: Despite similarities in health systems and Trans-Tasman Harmonization of medicines scheduling, New Zealand is more active than Australia in 'switching' (reclassifying) medicines from prescription to non-prescription. ...
    • Medicines reclassification from a pharmaceutical industry perspective: An international qualitative study
      Gauld, N.; Kelly, F.; Emmerton, Lynne; Kurosawa, N.; Bryant, L.; Buetow, S. (2018)
      Background: Widening access to medicines through reclassification (‘switching’) of medicines from prescription to non-prescription is an international trend generally welcomed by community pharmacists. Research has focused ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.